3-ethyl-1-[2-(1-ethylmorpholinium-1-yl)ethyl]-benzimidazolium diiodide monohydrate
dc.authorid | KUCUKBAY, HASAN/0000-0002-7180-9486 | |
dc.authorid | Yılmaz, Ülkü/0000-0002-2806-4781 | |
dc.authorwosid | KUCUKBAY, HASAN/A-5050-2019 | |
dc.authorwosid | YILDIRIM, Sema ÖZTÜRK/ABG-5085-2020 | |
dc.authorwosid | Yılmaz, Ülkü/AAA-7545-2020 | |
dc.contributor.author | Akkurt, M | |
dc.contributor.author | Yildirim, SÖ | |
dc.contributor.author | Küçükbay, H | |
dc.contributor.author | Yilmaz, Ü | |
dc.contributor.author | Büyükgüngör, O | |
dc.date.accessioned | 2024-08-04T20:14:44Z | |
dc.date.available | 2024-08-04T20:14:44Z | |
dc.date.issued | 2005 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | The title compound, C17H27N3O2+ . 2I(-) . H2O, was synthesized from 1-( 2- morpholinoethyl) benzimidazole and ethyl iodide in dimethylformamide. In the molecule, the benzimidazole ring is connected to the morpholine ring by an ethylene group. The crystal structure is stabilized by inter- and intramolecular O - H ... I, C - H ... O and C - H ... I interactions. | en_US |
dc.identifier.doi | 10.1107/S160053680403301X | |
dc.identifier.endpage | O303 | en_US |
dc.identifier.issn | 2056-9890 | |
dc.identifier.scopus | 2-s2.0-18544361910 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | O301 | en_US |
dc.identifier.uri | https://doi.org/10.1107/S160053680403301X | |
dc.identifier.uri | https://hdl.handle.net/11616/93931 | |
dc.identifier.volume | 61 | en_US |
dc.identifier.wos | WOS:000226692400123 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Int Union Crystallography | en_US |
dc.relation.ispartof | Acta Crystallographica Section E-Crystallographic Communications | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | 2,6-Disubstituted Morpholines | en_US |
dc.subject | Ring | en_US |
dc.subject | Antibacterial | en_US |
dc.subject | Derivatives | en_US |
dc.title | 3-ethyl-1-[2-(1-ethylmorpholinium-1-yl)ethyl]-benzimidazolium diiodide monohydrate | en_US |
dc.type | Article | en_US |